Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

New therapies are an urgent medical need in all breast cancer subgroups. Metabotropic glutamate receptor 1 (mGluR1) is suggested as a potential new molecular target. We examined the prevalence mGluR1 expression in different clinically relevant breast cancer subgroups and determined its association w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastiaansen, Anna E. M., Timmermans, A. Mieke, Smid, Marcel, van Deurzen, Carolien H. M., Hulsenboom, Esther S. P., Prager-van der Smissen, Wendy J. C., Foekens, Renée, Trapman-Jansen, Anita M. A. C., Sillevis Smitt, Peter A. E., Luider, Theo M., Martens, John W. M., vanDuijn, Martijn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749122/
https://www.ncbi.nlm.nih.gov/pubmed/33339858
http://dx.doi.org/10.1038/s41598-020-79248-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749122/
https://www.ncbi.nlm.nih.gov/pubmed/33339858
http://dx.doi.org/10.1038/s41598-020-79248-4

Ejemplares similares